Wingspan Releases New Product, SiteZone
BLUE BELL, PA --- Wingspan Technology announced the release of SiteZone, a solution for collaboration between sponsors, CROs, and site personnel. The cloud-based product provides one location for collecting and tracking investigator content.
Designed for the average internet user, SiteZone features an intuitive user interface, requiring little or no training at the site level. Investigators can access and sign certain eTMF documents, as well as upload documents that originate on site. Administrators can track the progress of individual sites and easily view missing documents.
“Clinical trials often require a global reach. SiteZone improves the overall workflow and saves time and resources throughout the course of a trial,” Wingspan CEO Troy Deck said. “We are offering Sponsors and CROs a way to quicken study startup, reduce costs for paper and site visits, and improve overall efficiency.”
SiteZone is comparable to site portal solutions. It features the components needed to manage user access, support site users, and expedite the collection and delivery of documents. Personal credentials are created and managed by Wingspan, taking the burden away from sponsors, and allowing site personnel to use SiteZone across trials and sponsors. SiteZone’s electronic signature feature makes it easy for sites to sign and submit documents and also eliminates the need for on-site storage of many paper documents.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Phase II ALPACA Trial Shows Lepodisiran Produces Significant, Sustained Lipoprotein(a) Reductions
March 31st 2025Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk factor for cardiovascular disease.
